| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Review |
1 Department of Cardiology, Children’s Hospital Boston, Boston, MA; 2 Division of Cardiovascular Medicine, Harvard Medical School, and Departments of Epidemiology and Nutrition, Harvard School of Public Health, Boston, MA.
aAddress correspondence to this author at: Department of Cardiology, Children’s Hospital Boston, 300 Longwood Avenue, Boston, MA 02115. Fax 617 730-0600; e-mail Sarah.deferranti{at}cardio.chboston.org
Background: As the prevalence of adiposity soars in both developed and developing nations, appreciation of the close links between obesity and disease increases. The strong relationships between excess adipose tissue and poor health outcomes, including cardiovascular disease, diabetes, and cancer, mandate elucidation of the complex cellular, hormonal, and molecular pathophysiology whereby adiposity initiates and maintains adverse health effects.
Content: In this report we review adipocyte metabolism and function in the context of energy imbalance and postprandial nutrient excess, including adipocyte hypertrophy and hyperplasia, adipocyte dysfunction, and other systemic consequences. We also discuss implications for laboratory evaluation and clinical care, including the role of lifestyle modifications. Chronic energy imbalance produces adipocyte hypertrophy and hyperplasia, endoplasmic reticulum stress, and mitochondrial dysfunction. These processes lead to increased intracellular and systemic release of adipokines, free fatty acids, and inflammatory mediators that cause adipocyte dysfunction and induce adverse effects in the liver, pancreatic β-cells, and skeletal muscle as well as the heart and vascular beds. Several specialized laboratory tests can quantify these processes and predict clinical risk, but translation to the clinical setting is premature. Current and future pharmacologic interventions may target these pathways; modest changes in diet, physical activity, weight, and smoking are likely to have the greatest impact.
Summary: Adipocyte endoplasmic reticulum and mitochondrial stress, and associated changes in circulating adipokines, free fatty acids, and inflammatory mediators, are central to adverse health effects of adiposity. Future investigation should focus on these pathways and on reversing the adverse lifestyle behaviors that are the fundamental causes of adiposity.
The following articles in journals at HighWire Press have cited this article:
|
|
 |
|
  S. Basseri, S. Lhotak, A. M. Sharma, and R. C. Austin The chemical chaperone 4-phenylbutyrate inhibits adipogenesis by modulating the unfolded protein response J. Lipid Res., December 1, 2009; 50(12): 2486 - 2501. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. D. Navaneethan, H. Yehnert, F. Moustarah, M. J. Schreiber, P. R. Schauer, and S. Beddhu Weight Loss Interventions in Chronic Kidney Disease: A Systematic Review and Meta-analysis Clin. J. Am. Soc. Nephrol., October 1, 2009; 4(10): 1565 - 1574. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Hu, J. Bielawski, F. Samad, A. H. Merrill Jr., and L. A. Cowart Palmitate increases sphingosine-1-phosphate in C2C12 myotubes via upregulation of sphingosine kinase message and activity J. Lipid Res., September 1, 2009; 50(9): 1852 - 1862. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Romaguera, T. Norat, T. Mouw, A. M. May, C. Bamia, N. Slimani, N. Travier, H. Besson, J. Luan, N. Wareham, et al. Adherence to the Mediterranean Diet Is Associated with Lower Abdominal Adiposity in European Men and Women J. Nutr., September 1, 2009; 139(9): 1728 - 1737. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Lobo, B. M. Wiczer, and D. A. Bernlohr Functional Analysis of Long-chain Acyl-CoA Synthetase 1 in 3T3-L1 Adipocytes J. Biol. Chem., July 3, 2009; 284(27): 18347 - 18356. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. H. A. Ronkainen, V. Kovanen, M. Alen, E. Pollanen, E.-M. Palonen, C. Ankarberg-Lindgren, E. Hamalainen, U. Turpeinen, U. M. Kujala, J. Puolakka, et al. Postmenopausal hormone replacement therapy modifies skeletal muscle composition and function: a study with monozygotic twin pairs J Appl Physiol, July 1, 2009; 107(1): 25 - 33. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Tsai, R. Zhang, W. Qiu, Q. Su, M. Naples, and K. Adeli Inflammatory NF-{kappa}B activation promotes hepatic apolipoprotein B100 secretion: evidence for a link between hepatic inflammation and lipoprotein production Am J Physiol Gastrointest Liver Physiol, June 1, 2009; 296(6): G1287 - G1298. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. Varma, A. Yao-Borengasser, N. Rasouli, G. T. Nolen, B. Phanavanh, T. Starks, C. Gurley, P. Simpson, R. E. McGehee Jr., P. A. Kern, et al. Muscle inflammatory response and insulin resistance: synergistic interaction between macrophages and fatty acids leads to impaired insulin action Am J Physiol Endocrinol Metab, June 1, 2009; 296(6): E1300 - E1310. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. J. Vieira, R. J. Valentine, K. R. Wilund, N. Antao, T. Baynard, and J. A. Woods Effects of exercise and low-fat diet on adipose tissue inflammation and metabolic complications in obese mice Am J Physiol Endocrinol Metab, May 1, 2009; 296(5): E1164 - E1171. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. S. Nunemaker, M. Chen, H. Pei, S. D. Kimble, S. R. Keller, J. D. Carter, Z. Yang, K. M. Smith, R. Wu, M. H. Bevard, et al. 12-Lipoxygenase-knockout mice are resistant to inflammatory effects of obesity induced by western diet Am J Physiol Endocrinol Metab, November 1, 2008; 295(5): E1065 - E1075. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Anderson and J. Borlak Molecular Mechanisms and Therapeutic Targets in Steatosis and Steatohepatitis Pharmacol. Rev., September 1, 2008; 60(3): 311 - 357. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. W.G. Redman The Endoplasmic Reticulum Stress of Placental Impoverishment Am. J. Pathol., August 1, 2008; 173(2): 311 - 314. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
